Xeris Pharmaceuticals Inc. shares rallied in the extended session Monday after the drug maker said its diabetes treatment showed positive results in a...
Xeris Pharmaceuticals Inc.
shares rallied in the extended session Monday after the drug maker said its diabetes treatment showed positive results in a mid-stage clinical study. Xeris shares surged 23% after hours, following a 4.6% decline in the regular session to close at $5.79. The company said a Phase 2 study showed that its ready-to-use glucagon "was adequate" to maintain normal blood sugar levels in Type 1 diabetes patients during and after moderate-to-high intensity aerobic exercise versus standard care.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
WW International extends Oprah Winfrey deal to 2025, shares rise'We had a softer start to last year, but the team has done an incredible job of galvanizing the business since then. We ended Q3 at 4.4 million members,” CEO of WW International Mindy Grossman said earlier today.
Read more »
Deutsche Bank says Apple 'unlikely to come close to repeating last year's returns'Deutsche Bank said despite last year's rally in Apple's stock, the iPhone maker's fundamentals are not keeping pace with the stock appreciation.
Read more »
Here’s what market forecaster Ed Yardeni sees for U.S. stocks in 2020No recession, modest economic growth, and tame inflation give financial markets a tailwind, writes Ed Yardeni.
Read more »
Most overpriced stocks in the market to avoid, 20% drop: Goldman Sachs - Business InsiderGoldman Sachs says these 10 stocks are dangerously overvalued and could tumble 20% — and their list includes Apple, which they see plunging 35% this year
Read more »
Alonso 11th after first stage of Dakar debut in Saudi ArabiaDouble Formula One world champion Fernando Alonso made a solid Dakar Rally debut...
Read more »
The elusive energy rally is finally on, says top technical analyst2020 could be the year energy finally rallies, according to Cornerstone Macro's Carter Worth.
Read more »